Healthcare Industry News: Wright Medical Group
News Release - October 3, 2007
Wright Medical Group, Inc. Announces Exclusive Agreement to Distribute the Foot and Ankle Product Line of A.M. Surgical, Inc.
Innovative Endoscopic Approach to Soft Tissue Decompression and Release Complements Wright's Growing Foot and Ankle Product PortfolioARLINGTON, Tenn.--(HSMN NewsFeed)--Wright Medical Group, Inc. (NASDAQ: WMGI ), a global orthopaedic medical device company, announced today that it has entered into an exclusive worldwide license and distribution agreement with A.M. Surgical, Inc., a Smithtown, New York-based company focused on providing endoscopic soft tissue release products for orthopaedic and foot and ankle surgeons.
The ten-year agreement includes all of A.M. Surgical's current and future products for the foot and ankle market. Products currently available include the A.M. Surgical foot and ankle endoscopic tissue release product line which consists of the A.M. EPF (plantar fascia release), A.M. UDIN (interdigital nerve decompression) and A.M. EGR (gastrocnemius release). These three systems address the decompression and soft tissue release procedures most commonly performed by foot and ankle surgeons. Wright will begin offering the A.M. foot and ankle tissue release systems through its U.S. sales force immediately, with expansion into the Company's international markets occurring in 2008.
"Minimally invasive tissue release is a rapidly growing area in foot and ankle surgery," commented John T. Treace, Vice President of Marketing for Wright's extremity products. "The A.M. Surgical product line is highly innovative and complementary to our rapidly expanding line of reconstructive and biologic products for foot surgery. We look forward to the opportunity to expand education and delivery of the A.M. devices to foot and ankle surgeons on a worldwide basis, as well as the opportunity for future collaboration with A.M. Surgical to build upon this exciting technology platform."
About Wright
Wright Medical Group, Inc. is a global orthopaedic medical device company specializing in the design, manufacture and marketing of reconstructive joint devices and biologics. The Company has been in business for more than 50 years and markets its products in over 60 countries worldwide.
Safe-Harbor Statement
This press release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. All statements made in this press release, other than statements of historical fact, are forward-looking statements. Forward-looking statements reflect management's current knowledge, assumptions, beliefs, estimates, and expectations and express management's current views of future performance, results, and trends. The Company wishes to caution readers that actual results might differ materially from those described in the forward-looking statements. Forward-looking statements are subject to a number of risks and uncertainties, including the factors discussed in the Company's filings with the Securities and Exchange Commission (including the Company's annual report on Form 10-K for the year ended December 31, 2006 under the heading, "Risk Factors" and its quarterly reports), which could cause the Company's actual results to materially differ from those described in the forward-looking statements. Although the Company believes that the forward-looking statements are accurate, there can be no assurance that any forward-looking statement will prove to be accurate. A forward-looking statement should not be regarded as a representation by the Company that the results described therein will be achieved. The Company wishes to caution readers not to place undue reliance on any forward-looking statement. The forward-looking statements are made as of the date of this press release. The Company assumes no obligation to update any forward-looking statement after this date.
Source: Wright Medical Group
Issuer of this News Release is solely responsible for its
content.
Please address inquiries directly to the issuing company.
